Paid Clinical Trials in Tucson, AZ
As of September 2026, 460 paid clinical trials are recruiting in Tucson, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tucson offers studies at sites including University of Arizona for conditions such as Obesity, Overweight, Breast Cancer, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tucson
Trials by drug in Tucson
Filter results
Newly added in Tucson
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
411 clinical trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Top Research Study Locations in Tucson
Researchers run research studies in Tucson, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Arizona | Amblyopia, Breast Cancer, Cardiovascular Diseases | 81 |
| Banner University Medical Center - Tucson | Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Diffuse Large B-Cell Lymphoma | 50 |
| University of Arizona Cancer Center-North Campus | Acute Myeloid Leukemia, Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | 35 |
| University of Arizona Cancer Center | Advanced Solid Tumor, Breast Cancer, Colorectal Cancer | 28 |
| The University of Arizona Cancer Center | Advanced Solid Tumor, Breast Cancer, Unresectable Solid Tumor | 13 |
| Del Sol Research Management, LLC | Chronic Idiopathic Constipation (CIC), Contraception, Liver Fibrosis | 9 |
| Center for Neurosciences | Focal Epilepsy, Autoimmune Encephalitis (AE), Epilepsy | 8 |
| Pima Heart and Vascular | Heart Failure, Atrial Fibrillation, Deep Venous Thrombosis | 8 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Chickenpox, Colonic Neoplasms | 6 |
| Banner University Medical Center | Arteriovenous Fistula, Atrial Fibrillation, Blood Pressure Measurement in Pregnancy | 6 |
| The University of Arizona Cancer Center - North Campus | Neoplasm Metastasis, Carcinoma, Non-Small-Cell Lung, Breast Cancer, Metastatic | 6 |
| Arizona Liver Health - Tucson | Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis | 5 |
| Eclipse Clinical Research | Cardiovascular Disease, Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD) | 5 |
| Tucson Medical Center | Mitral Regurgitation, Aortic Stenosis, Aortic Valve Disease | 5 |
| Noble Clinical Research | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 4 |
| The University of Arizona | Breathing Exercises, Breathing Techniques, CAR T-Cell Therapy | 4 |
| Tucson Cystic Fibrosis Center | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| University of Arizona Cancer Center - Prevention Research Clinic | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Atypical Ductal Hyperplasia | 4 |
| University of Arizona Cancer Center-Orange Grove Campus | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 4 |
| Adobe Clinical Research, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| Arizona Cancer Center at UMC North/University Medical Center | Bladder Cancer, Brain Metastases, Cancer Survivors | 3 |
| Arizona Clinical Trials | Obesity or Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3 |
| Del Sol Research Management | Lower Urinary Tract Symptoms (LUTS), Major Depressive Disorder, Overweight or Obesity and Elevated Liver Fat | 3 |
| Pima Heart | Diabetes Mellitus, Type 2, Obesity, Atherosclerosis | 3 |
| Pima Heart & Vascular | Coronary Artery Disease, High-Risk Percutaneous Coronary Intervention, Ischemic Heart Disease | 3 |
Active & Upcoming Studies in Tucson (2026)
Recruiting trials in Tucson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (153 active studies)
- Pilot Feasibility Study of a Dyadic Culinary Nutrition Intervention · University of Arizona
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
Diabetes & metabolic (37 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
Cardiovascular (35 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
Neurology & pain (29 active studies)
- A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults · Phase 4 · Sairam Parthasarathy
- Hypknowledge Nationwide Sleep Extension · University of Arizona
Mental health & behavior (12 active studies)
- Brexanolone Lifting Outcomes Of Moms · Phase 3 · Lipocine Inc.
- Lumateperone for Late-Life Depression · Phase 3 · Eric Lenze
Eye & vision (4 active studies)
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration · Phase 3 · 4D Molecular Therapeutics
- (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000 · Carl Zeiss Meditec-Dublin CoCe
Vaccines (2 active studies)
- A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID · Phase 2, Phase 3 · HealthBio, Inc.
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID · Phase 3 · Wes Ely
HIV / STI (1 active study)
- Wellness Intervention for Smoking and HIV · University of Arizona
Pediatric (1 active study)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Tucson
- Obesity (13 active studies)
- Overweight (11 active studies)
- Breast Cancer (10 active studies)
- Acute Myeloid Leukemia (8 active studies)
- Hypertension (8 active studies)
- Cardiovascular Diseases (7 active studies)
Leading research sponsors in Tucson
- University of Arizona
- Eli Lilly and Company
- National Cancer Institute (NCI)
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Tucson?
There are approximately 460 recruiting clinical trials in Tucson, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tucson pay participants?
Most recruiting trials in Tucson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tucson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tucson?
The most common conditions under active study in Tucson include Obesity (13), Overweight (11), Breast Cancer (10), Acute Myeloid Leukemia (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tucson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tucson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tucson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tucson?
Recruiting research sites in Tucson include University of Arizona, Banner University Medical Center - Tucson, University of Arizona Cancer Center-North Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tucson right now?
The largest active categories in Tucson are Cancer & tumors (153), Diabetes & metabolic (37), Cardiovascular (35). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.